Lung Cancer

EDU 17 - (INTERACTIVE) Increasing Role of Radiation Therapy and Multidisciplinary Management of Thymic Malignancies

4:15 PM - 5:45 PM
Location: Room 007 C/D

Session Type: Educational
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits

This session was proudly submitted as a joint session with ITMIG. A multidisciplinary expert panel will present updates on the significant progress in each field and aspect of thymic malignancies. Robert Korst, a thoracic surgeon and president of ITMIG, will present surgical standards and minimally-invasive surgical techniques and the IASLC/ITMIG TNM staging system. Alexander Marx, a world-renowned pathologist and leader for the new WHO classification for thymic malignancies, will present the new WHO classification system. Arun Rajan, a thoracic oncologist and thymic tumor experts at the NCI, will present on the role of chemotherapy and novel therapies including sunitinib and immunotherapy for thymic malignancies. Charles Simone, an expert on proton therapy, will present on modern radiation techniques including proton therapy for thymic tumors. Andreas Rimner, moderator of the session and ITMIG vice-president-elect, will present an updated review of the key studies for radiation therapy in thymic tumors that led to changes in the NCCN guidelines.

Learning Objectives:


Andreas Rimner, MD

Memorial Sloan Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center: Assistant Attending: Employee

Astra Zeneca: Research Grants; Boehringer Ingelheim: Research Grants; Pfizer: Research Grants; Varian Medical Systems: Research Grants

International Mesothelioma Interest Group: Board Member; International Thymic Malignancies Interest Group: Vice-President Elect

I, Andreas Rimner, MD, am an Attending Physician and leader of the thoracic group in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center, New York. I am a graduate of the School of Medicine at the Eberhard-Karls-University in Tuebingen, Germany. After a postdoctoral fellowship I completed my transitional year and radiation oncology residency, all at Memorial Sloan Kettering Cancer Center. In 2010 I joined the faculty in the Department of Radiation Oncology. I currently serve as the ASTRO Annual Meeting Vice-Chair for the Lung Track, a member of the ASTRO Lung Resource Panel, and have participated in multiple additional ASTRO guideline committees. I am an ABR board exam member for Thoracic Cancers and Sarcomas. I am a board member of the International Mesothelioma Interest Group and the Vice-President Elect of the International Thymic Malignancies Interest Group. I have a particular interest in clinical and translational research that explores drug-radiation combination therapies, novel approaches and improvements in RT imaging and delivery, and normal organ complications of RT.


Send Email for Andreas Rimner


EDU 17 - (INTERACTIVE) Increasing Role of Radiation Therapy and Multidisciplinary Management of Thymic Malignancies

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for EDU 17 - (INTERACTIVE) Increasing Role of Radiation Therapy and Multidisciplinary Management of Thymic Malignancies